Vasopressin receptor agonist

This page covers all Vasopressin receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting V2 vasopressin receptor (AVPR2), V1A and V2 receptors.

Targets

V2 vasopressin receptor (AVPR2) · V1A and V2 receptors

Marketed (1)

• DDAVP · Chang, Steve S., M.D. · Endocrinology, Hematology
  DDAVP (desmopressin) is a synthetic vasopressin analog that acts as an antidiuretic hormone (ADH) receptor agonist to increase water reabsorption in the kidneys and promote von Willebrand factor release from endothelial cells.

Phase 3 pipeline (1)

• Vasopressin administration · Assistance Publique Hopitaux De Marseille · Cardiovascular
  Vasopressin acts as a potent vasoconstrictor by stimulating V1A receptors on vascular smooth muscle cells, causing blood vessels to constrict.